In vivo assessment of the role of aggregated tau in preclinical and prodromal Alzheimer's disease

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1105538

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Subtle changes in the brain precede an Alzheimer’s disease (AD) diagnosis by 20-30 years. These changes provide an incredible opportunity to diagnose and treat AD; however, our understanding of them, remains limited. We aim to use new imaging technologies to investigate these subtle changes in the preclinical AD brain. This will give us a greater understanding of how these early changes effect AD progression and whether we can use this information to improve the diagnosis and treatment of AD.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2020

Funding Scheme: Targeted Calls

Funding Amount: $612,269.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Neurosciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Alzheimer disease | amyloid beta-protein | diagnostic imaging | neurofibrillary tangles | positron emission tomography (PET)

Related Links